weekly-equity-report by epicresearch 13 may 2013

7/30/2019 Weekly-equity-report by Epicresearch 13 May 2013

1/4

WEEKLYNEWS

EGoM to mull diverting KG-D6 gas from fer

power cos

The oil ministry has mooted a new allocation polic

the KG-D6 gas. If that goes through, the power sec

gain will be the fertilizer sectors loss.The Empow

Group of Ministers (EGoM) notice has been finalise

the oil ministry but the date of the meeting has stil

been notified by government. EGoM is looking

diverting KG-D6 gas supply to the tune of almost 1

mmscmd to the power sector. Nearly 9 mmscmd of

will be coming from the fertilizer sector which w

course impact the urea production in the country.

urea production is expected to fall by 4.54 million m

tonnes and increase the subsidy burden by Rs 5

crore.

"Tata Power to develop hydro projects

$700mln in Georgia

Tata Power has signed an agreement to develop

hydro projects in Georgia for the sale of power, prim

to Turkey, at an estimated cost of about USD

million, the company said in a statement on Friday

hydro projects, expected to have an aggregate cap

of 400 megawatts, would be developed in three ph

with the first phase expected to be completed be

mid-2016.

http://www.epicresearch.co 09752199966

WEEKLY EQUITY

NEWSLETTER13

THMAY 2013

MARKET UPDATE:-

Nif ty up by 150 pts and

settl e at 6094.00

Bank Nif ty up by 360 ptsat 12752.30
http://www.epicresearch.co/http://www.epicresearch.co/http://www.epicresearch.co/


2/4

NIFTY WEEKLY PIVOTS

http://www.epicresearch.co 09752199966

MARKETANALYSIS GAINS IN WORLD STOCKS AND STRONG INFLOW FROM FOREIGN INSTITUTIONAL INVESTORS (FIIS) SENT

KEY BENCHMARK INDICES SURGING, WITH THE BAROMETER INDEX, THE S&PBSESENSEX HITTING OV14 WEEK HIGH ABOVE THE PSYCHOLOGICAL 20,000 MARK.THE CNXNIFTY REACHED OVER2-YEARCLOSING HIGH ABOVE THE PSYCHOLOGICAL 6,000 MARK.THE MARKET GAINED IN FOUR OUT OF FIVETRADING SESSIONS IN THE WEEK ENDED FRIDAY,10MAY2013.

THE S&PBSESENSEX JUMPED 506.98 POINTS OR2.59% TO 20,082.62, ITS HIGHEST CLOSING LEVELSINCE 28JANUARY2013.THE CNXNIFTY ROSE 150.75 POINTS OR2.53% TO 6,094.75, ITS HIGHESTCLOSING LEVEL SINCE 4JANUARY2011.

THE S&PBSEMID-CAP INDEX GAINED 2.25%.THE S&PBSESMALL-CAP INDEX ROSE 2.22%.BOTHTHESE INDICES UNDERPERFORMED THE SENSEX.

FROM THE 30-SHARE SENSEX PACK,22 STOCKS ROSE AND 8 STOCKS FELL. FMCG MAJORHINDUSTAN UNILEVER(HUL) ROSE 2.18% TO RS 584.90.THE STOCK HAD HIT RECOR

HIGH OF RS 597 IN INTRADAY TRADE ON 30APRIL 2013.THE COMPANY ON 8MAY2013, SAID THAT ASPER THE TENTATIVE SCHEDULE OF ACTIVITY, THE OPEN OFFER BY ITS PARENT FIRM UNILEVERPLC TO BADDITIONAL 22.52% STAKE IN THE COMPANY AT RS 600 PER SHARE WOULD BEGIN ON 21JUNE 2013 ACLOSE ON 4JULY2013.UNILEVERPLC PLANS TO HIKE ITS STAKE IN HINDUSTAN UNILEVER TO 75%

THROUGH THE OPEN OFFER FROM ITS CURRENT HOLDING OF 52.48%

EXPERT OPINION

NIFTY BANK NIFTY

Nifty looks Bearish Bank Nifty looks Bearish

Strategy: Sell on rise Strategy: Sell on rise

Support: 6020 Support: 12700

Resistance: 6120 Resistance: 12800

NIFTY WEEKLY PIVOTS

PIVOTS R4 R3 R2 R1 PP S1 S2 S3 S4

NIFTY 6573 6396 6219 6156 6042 5979 5865 5688 5511
http://www.epicresearch.co/http://www.epicresearch.co/http://www.epicresearch.co/free-trial-formhttp://www.epicresearch.co/free-trial-formhttp://www.epicresearch.co/free-trial-formhttp://www.epicresearch.co/


3/4

//www.epicresearch.co 09752199966

NIFTY WEEKLY CHART

WEEKLY BANK NIFTY CHART
http://www.epicresearch.co/http://www.epicresearch.co/http://www.epicresearch.co/free-trial-formhttp://www.epicresearch.co/free-trial-formhttp://www.epicresearch.co/free-trial-formhttp://www.epicresearch.co/


4/4

.

GAINERS AND LOOSERS

WEEKLY NIFTY GAINERS

SCRIPS RATE VOL. (000) PR.

CLOSE

NET

CHANGE

% CHANGE

Tata

Motors309.05 8403.04 285.60 23.45 8.21

Hindalco 105.95 4464.58 98.05 7.90 8.06

Indusind 505.65 1386.74 468.05 37.60 8.03

ITC 353.15 5787.00 330.70 22.45 6.79

Hero

MotoCorp1704.95 203.39 1611.40 93.55 5.81

WEEKL Y NIFTY LOOSERS

SCRIPS RATE VOL.

(000)

PR. CLOSE NET

CHANGE

% CHANGE

Coal India 299.70 1577.25 318.75 -19.05 -5.98

Sun Pharma 935.05 1393.99 984.70 -49.65 -5.04

NTPC 155.00 10176.07 159.30 -4.3 -2.70

Jindal Steel 311.40 4210.77 318.45 -7.05 -2.21

Ranbaxy Labs 444.05 361.55 449.80 -5.75 -1.28

Disclaimer

The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any

responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.

Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on

sources that we consider reliable.

This material is for personal information and based upon it & takes no responsibility

The information given herein should be treated as only factor, while making investment decision. The report does not provide individually

tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and

encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on

the information given in this report, which is in violation of rules and regulations of NSE and BSE.

The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all

estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks

recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views

expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of

the information is the acceptance of this disclaimer.

All Rights Reserved.Investment in equity & bullion market has its own risks.

We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any

financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to

buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls

or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious

Legal Actions can be taken.

weekly-equity-report by epicresearch 13 may 2013

Documents